Comparison of preplanning and intraoperative planning for I-125 prostate brachytherapy

Japanese Journal of Clinical Oncology

Volumn 43, Issue 4, 2013, Pages 383-389

  Yoshida, Kayo ^a   Ohashi, Toshio ^b   Yorozu, Atsunori ^a   Toya, Kazuhito ^a   Nishiyama, Toru ^a   Saito, Shiro ^a   Hanada, Takashi ^b   Shiraishi, Yutaka ^b   Shigematsu, Naoyuki ^b  

^a NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Brachytherapy; Intraoperative planning; Preplanning; Prostate cancer

Indexed keywords

IODINE 125; PROSTATE SPECIFIC ANTIGEN;

ACUTE TOXICITY; ARTICLE; BIOCHEMICAL FAILURE FREE SURVIVAL; BONE SCINTISCANNING; BRACHYTHERAPY; BRACHYTHERAPY IMPLANT; CANCER HORMONE THERAPY; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; GASTROINTESTINAL TOXICITY; GLEASON SCORE; HIGH RISK POPULATION; HOSPITAL DISCHARGE; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSTATE CANCER; PROSTATE VOLUME; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT PLANNING; URINE RETENTION; UROGENITAL TRACT DISEASE;

BRACHYTHERAPY; HUMANS; IODINE RADIOISOTOPES; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOMETRY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 84875802594     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hys240     Document Type: Article

References (24)

1. D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. J Am Med Assoc 1998;280:969-74.
2. Potters L, Klein EA, Kattan MW, et al. Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation. Radiother Oncol 2004;71:29-33.
3. Sylvester JE, Grimm PD, Eulau SM, Takamiya RK, Naidoo D. Permanent prostate brachytherapy preplanned technique: the modern Seattle method step-by-step and dosimetric outcomes. Brachytherapy 2009;8:197-206.
4. Beaulieu L, Aubin S, Taschereau R, Pouliot J, Vigneault E. Dosimetric impact of the variation of the prostate volume and shape between pretreatment planning and treatment procedure. Int J Radiat Oncol Biol Phys 2002;53:215-21.
5. Nag S, Ciezki JP, Cormack R, et al. Intraoperative planning and evaluation of permanent prostate brachytherapy: report of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys 2001;51:1422-30.
6. Stock RG, Stone NN, Wesson MF, DeWyngaert JK. A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation. Int J Radiat Oncol Biol Phys 1995;32:219-25.
7. Shanahan TG, Nanavati PJ, Mueller PW, Maxey RB. A comparison of permanent prostate brachytherapy techniques: preplan vs. hybrid interactive planning with postimplant analysis. Int J Radiat Oncol Biol Phys 2002;53:490-6.
8. Potters L, Calguaru E, Thornton KB, Jackson T, Huang D. Toward a dynamic real-time intraoperative permanent prostate brachytherapy methodology. Brachytherapy 2003;2:172-80.
9. Zelefsky MJ, Yamada Y, Marion C, et al. Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy. Int J Radiat Oncol Biol Phys 2003;55:956-63.
10. Shah JN, Wuu CS, Katz AE, Laguna JL, Benson MC, Ennis RD. Improved biochemical control and clinical disease-free survival with intraoperative versus preoperative preplanning for transperineal interstitial permanent prostate brachytherapy. Cancer J 2006;12:289-97.
11. Matzkin H, Chen J, Stenger A, Agai R, Mabjeesh NJ. Prospective comparison of PSA kinetics following two different prostate cancer brachytherapy planning methods: preoperative and real-time intraoperative dosimetry planning. Urol Oncol 2012;30:379-85.
12. Ohashi T, Yorozu A, Toya K, Saito S, Momma T. Acute urinary morbidity following I-125 prostate brachytherapy. Int J Clin Oncol 2005;10:262-8.
13. Ohashi T, Yorozu A, Toya K, et al. Rectal morbidity following I-125 prostate brachytherapy in relation to dosimetry. Jpn J Clin Oncol 2007;37:121-6.
14. Matzkin H, Kaver I, Bramante-Schreiber L, Agai R, Merimsky O, Inbar M. Comparison between two iodine-125 brachytherapy implant techniques: pre-planning and intra-operative by various dosimetry quality indicators. Radiother Oncol 2003;68:289-94.
15. Merrick GS, Butler WM, Dorsey AT, Lief JH. Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation. Tech Urol 2001;7:233-40.
16. Grimm PD, Blasko JC, Sylvester JE, et al. Technical improvement in permanent seed implantation: a two-stage brachytherapy system. Description and comparison with current technique. Brachytherapy 2004;3:34-40.
17. Sylvester JE, Grimm PD, Wong J, Galbreath RW, Merrick G, Blasko JC. Fifteen-year biochemical relapse-free survival, causespecific survival, and overall survival following I(125) prostate brachytherapy in clinically localized prostate cancer: Seattle experience. Int J Radiat Oncol Biol Phys 2011;81:376-81.
18. Crook J, Borg J, Evans A, et al. 10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1,100 patients. Int J Radiat Oncol Biol Phys 2011;80:1323-9.
19. Morris WJ, Keyes M, Palma D, et al. Population-based study of biochemical and survival outcomes after permanent 125I brachytherapy for low- and intermediate-risk prostate cancer. Urology 2009;73:860-5; discussion 5-7.
20. Stone NN, Stone MM, Rosenstein BS, Unger P, Stock RG. Influence of pretreatment and treatment factors on intermediate to long-term outcome after prostate brachytherapy. J Urol 2011;185:495-500.
21. Roach M, 3rd, Hanks G, Thames H, Jr, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006;65:965-74.
22. Zelefsky MJ, Yamada Y, Cohen GN, et al. Intraoperative real-time planned conformal prostate brachytherapy: post-implantation dosimetric outcome and clinical implications. Radiother Oncol 2007;84:185-9.
23. Raben A, Rusthoven KE, Sarkar A, et al. Favorable toxicity and biochemical control using real-time inverse optimization technique for prostate brachytherapy. Brachytherapy 2009;8:297-303.
24. Fagundes HM, Keys RJ, Wojcik MF, Radden MA, Bertelsman CG, Cavanagh WA. Transperineal TRUS-guided prostate brachytherapy using loose seeds versus RAPIDStrand: a dosimetric analysis. Brachytherapy 2004;3:136-40.